AFA
GILD icon

AA Financial Advisors’s Gilead Sciences GILD Stock Holding History

AA Financial Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$429K Sell
3,398
-19
-0.6% -$2.5K 0.05% 161
2026
Q1 		$476K Sell
3,417
-565
-14% -$79.1K 0.07% 142
2025
Q4 		$489K Sell
3,982
-115
-3% -$14K 0.09% 130
2025
Q3 		$455K Sell
4,097
-153
-4% -$17.4K 0.09% 120
2025
Q2 		$471K Hold
4,250
– – 0.1% 113
2025
Q1 		$476K Buy
4,250
+408
+11% +$42.1K 0.12% 105
2024
Q4 		$355K Buy
3,842
+1,293
+51% +$116K 0.09% 127
2024
Q3 		$214K Buy
+2,549
New +$195K 0.06% 164

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

AA Financial Advisors's GILD Position: Q2 2026 in Review

AA Financial Advisors reduced its Gilead Sciences (GILD) stake by 0.56% in Q2 2026, selling an estimated $2.5K and leaving 3,398 shares worth $429K. The position accounts for 0.05% of the portfolio, ranked #161.

AA Financial Advisors first reported a position in GILD in Q3 2024 and has held it in 8 quarters since. The position peaked at $489K in Q4 2025. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • AA Financial Advisors held 3,398 shares of Gilead Sciences worth $429K as of Q2 2026.
  • AA Financial Advisors sold 19 Gilead Sciences shares in Q2 2026, an estimated $2.5K.
  • Gilead Sciences made up 0.05% of AA Financial Advisors's portfolio in Q2 2026, its #161 holding.
  • AA Financial Advisors first reported a position in Gilead Sciences in Q3 2024 and has held it in 8 quarters since.
  • AA Financial Advisors's Gilead Sciences position peaked at $489K in Q4 2025.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on AA Financial Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.